Zynlonta (Loncastuximab Tesirine) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Zynlonta. Always confirm against the full prescribing information.
100 interactions
Abemaciclib
The serum concentration of Abemaciclib can be increased when it is combined with Loncastuximab tesirine.
Level 2 evidence
Abrocitinib
The serum concentration of Loncastuximab tesirine can be increased when it is combined with Abrocitinib.
Level 2 evidence
Adagrasib
The serum concentration of Loncastuximab tesirine can be increased when it is combined with Adagrasib.
Level 2 evidence
Afatinib
The serum concentration of Loncastuximab tesirine can be increased when it is combined with Afatinib.
Level 2 evidence
Ambrisentan
The serum concentration of Loncastuximab tesirine can be increased when it is combined with Ambrisentan.
Level 2 evidence
Amiodarone
The serum concentration of Loncastuximab tesirine can be increased when it is combined with Amiodarone.
Level 2 evidence
Apalutamide
The serum concentration of Loncastuximab tesirine can be decreased when it is combined with Apalutamide.
Level 1 evidence
Apixaban
The serum concentration of Loncastuximab tesirine can be increased when it is combined with Apixaban.
Level 2 evidence
Arsenic trioxide
The serum concentration of Loncastuximab tesirine can be increased when it is combined with Arsenic trioxide.
Level 2 evidence
Articaine
The risk or severity of methemoglobinemia can be increased when Loncastuximab tesirine is combined with Articaine.
Level 1 evidence
Asciminib
The serum concentration of Loncastuximab tesirine can be increased when it is combined with Asciminib.
Level 1 evidence
Asunaprevir
The serum concentration of Loncastuximab tesirine can be increased when it is combined with Asunaprevir.
Zynlonta (Loncastuximab Tesirine) has 404 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Zynlonta (Loncastuximab Tesirine) has 0 major, 242 moderate, and 162 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Zynlonta. Always confirm against the full prescribing information.